Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say 
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William Blair 37th Annual Growth Stock Conference on June 13, 2017 at 2:10 p.m. Central Time in Chicago.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's proprietary Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 [email protected]
